The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

However, at Urban List we know the source for the best wardrobe staples can actually be found right under our noses in the form of local Australian labels. With an almost endless pool of independent ...